SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950134-09-007402
Filing Date
2009-04-13
Accepted
2009-04-13 13:57:18
Documents
2
Group Members
BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND V, L.P.BAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f52125sc13d.htm SC 13D 95489
2 EX-99.1 f52125exv99w1.htm EX-99.1 2124
  Complete submission text file 0000950134-09-007402.txt   99885
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81034 | Film No.: 09746327
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 4156763830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D